PUBLISHER: IMARC | PRODUCT CODE: 1467630
PUBLISHER: IMARC | PRODUCT CODE: 1467630
The global gene expression analysis market size reached US$ 5.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 11.0 Billion by 2032, exhibiting a growth rate (CAGR) of 8.6% during 2024-2032.
Gene expression analysis (GEA) is the method of extracting data from a gene to investigate the behaviour of biological systems. It involves different processes such as gene transcription, translation, post-translational modification of protein and RNA splicing. The data obtained from this analysis is used for the production of proteins, Ribonucleic Acid (RNA) and various microbiological products. They are further utilized for the development of new drugs and improving the existing diagnostic methods. GEA is now widely considered to be essential in explaining the mechanisms that cause numerous medical ailments, owing to which it finds extensive applications in pharmacogenomics, biomarking, toxicology and diagnostics.
The increasing adoption of targeted molecular therapeutics, along with the growing demand for personalized medicines, is among the key factors driving the growth of the market. GEA has proven to be a powerful tool in molecular biology studies, which are used to understand the functioning of genes, diagnose ailments and facilitate drug development. Furthermore, the growing prevalence of chronic diseases, such as cancer, tuberculosis, and cardiovascular and genetic disorders is providing a significant boost to the market growth. Additionally, the development of personalized medicines to cure these ailments has enabled the modifications of diagnostic and treatment methods according to the individual patient requirement. Moreover, various technological advancements, such as the advent of Next Generation Sequencing (NGS), along with the development of genomic databases, higher success rates of GEA and enhanced focus on research and development (R&D) in gene therapy, are further projected to drive the market growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global gene expression analysis market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on products & services, technology, capacity and end-user.
Consumables
Instruments
Services
Polymerase Chain Reaction (PCR)
Next Generation Sequencing (NGS)
DNA Microarray
Sanger Sequencing
Others
Low-to Mid-Plex Gene Expression Analysis
High-Plex Gene Expression Analysis
Pharmaceutical and Biotech Companies
Academic Institutes and Research Centers
Others
North America
United States
Canada
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Latin America
Brazil
Mexico
Argentina
Colombia
Chile
Peru
Others
Middle East and Africa
Turkey
Saudi Arabia
Iran
United Arab Emirates
Others
The competitive landscape of the industry has also been examined with some of the key players being Agilent Technologies, Inc., BGI Genomics Co., Ltd., Bio-Rad Laboratories, Inc., Eurofins GSC Lux SARL, F. Hoffmann-La Roche Ltd, GE Healthcare, Illumina, Inc., Oxford Gene Technology IP Limited, Pacific Biosciences of California Inc., PerkinElmer Inc., QIAGEN GmbH, Thermo Fisher Scientific Inc. etc.